Anna Evans Phillips, Joseph Bejjani, Phil A Hart, Mitchell L Ramsey, Vikesh K Singh, Peter J Lee, Dhiraj Yadav, Georgios I Papachristou
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2024;24(4):505-510
PMID: 38485543
Exocrine pancreatic dysfunction (EPD) is a malabsorptive complication of pancreatic disorders that can lead to a host of symptoms ranging from flatulence to diarrhea and contribute to weight loss and metabolic bone disease. It is increasingly recognized to occur after acute pancreatitis (AP), including episodes with mild severity. The risk of developing EPD after AP is influenced by a range of factors, including the degree of acinar cell destruction and inflammation during AP, and persistent structural derangements following AP. In this article, we discuss the epidemiology, pathophysiology, and clinical management of EPD after AP while highlighting key knowledge gaps.
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.